3rd Department of Internal Medicine, Semmelwies University, Budapest, Hungary.
J Neuroinflammation. 2011 Dec 29;8:185. doi: 10.1186/1742-2094-8-185.
A number of data indicate that the lectin pathway of complement activation contributes to the pathophysiology of ischemic stroke. The lectin pathway may be triggered by the binding of mannose-binding lectin (MBL), ficolin-2 or ficolin-3 to different ligands. Although several papers demonstrated the significance of MBL in ischemic stroke, the role of ficolins has not been examined.
Sera were obtained within 12 hours after the onset of ischemic stroke (admission samples) and 3-4 days later (follow-up samples) from 65 patients. The control group comprised 100 healthy individuals and 135 patients with significant carotid stenosis (patient controls). The concentrations of ficolin-2 and ficolin-3, initiator molecules of the lectin complement pathway, were measured by ELISA methods. Concentration of C-reactive protein (CRP) was also determined by a particle-enhanced immunturbidimetric assay.
Concentrations of both ficolin-2 and ficolin-3 were significantly (p < 0.001) decreased in both the admission and in the follow-up samples of patients with definite ischemic stroke as compared to healthy subjects. Concentrations of ficolin-2 and ficolin-3 were even higher in patient controls than in healthy subjects, indicating that the decreased levels in sera during the acute phase of stroke are related to the acute ischemic event. Ficolin-3 levels in the follow-up samples inversely correlated with the severity of stroke indicated by NIH scale on admission. In follow-up samples an inverse correlation was observed between ficolin-3 levels and concentration of S100β, an indicator of the size of cerebral infarct. Patients with low ficolin-3 levels and high CRP levels in the follow up samples had a significantly worse outcome (adjusted ORs 5.6 and 3.9, respectively) as measured by the modified Rankin scale compared to patients with higher ficolin-3 and lower CRP concentrations. High CRP concentrations were similarly predictive for worse outcome, and the effects of low ficolin-3 and high CRP were independent.
Our findings indicate that ficolin-mediated lectin pathways of complement activation contribute to the pathogenesis of ischemic stroke and may be additive to complement-independent inflammatory processes.
多项数据表明补体激活的凝集素途径参与了缺血性脑卒中的病理生理学过程。该途径可能由甘露聚糖结合凝集素(MBL)、ficolin-2 或 ficolin-3 与不同配体的结合而触发。尽管有几篇论文证明了 MBL 在缺血性脑卒中中的重要性,但 ficolin 的作用尚未被研究。
在缺血性脑卒中发病后 12 小时内(入院样本)和 3-4 天后(随访样本)从 65 名患者中采集血清。对照组包括 100 名健康个体和 135 名有明显颈动脉狭窄的患者(患者对照)。通过 ELISA 方法测量 ficolin-2 和 ficolin-3(凝集素补体途径的起始分子)的浓度。通过颗粒增强免疫比浊法测定 C 反应蛋白(CRP)的浓度。
与健康受试者相比,在入院和随访样本中,明确的缺血性脑卒中患者的 ficolin-2 和 ficolin-3 浓度均显著降低(p<0.001)。在患者对照中,ficolin-2 和 ficolin-3 的浓度甚至高于健康受试者,这表明在脑卒中急性发作期间血清中浓度降低与急性缺血事件有关。在随访样本中,ficolin-3 水平与 NIH 量表上入院时的脑卒中严重程度呈负相关。在随访样本中,ficolin-3 水平与 S100β浓度呈负相关,S100β是脑梗死大小的指标。在随访样本中,CRP 水平较高的患者的 ficolin-3 水平较低,其改良后的 Rankin 量表评分明显较差(调整后的 OR 值分别为 5.6 和 3.9)。CRP 浓度较高的患者预后同样较差,而 ficolin-3 浓度较低和 CRP 浓度较高的影响是独立的。
我们的研究结果表明,ficolin 介导的补体激活凝集素途径参与了缺血性脑卒中的发病机制,并且可能与补体非依赖性炎症过程相加。